AbbVie Inc. (ABBV)

Exchange: New York Stock Exchange

Price: 72.99 (Close)



52 Week range 200d Moving Avg. Beta
65.05 – 100.23 83.08 0.93
Dividend Dividend Yield Ex-Dividend date
4.06 5.56% 2019-07-12
P/E Ratio Latest EPS Latest EPS Date
20.91 3.68 2018-12-31
Dividend Aristocrat


AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson’s disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.


Sector: Industry:
Health Technology Pharmaceuticals: Major


AbbVie Inc. (ABBV) Performance

The chart below displays the performance (%) of AbbVie Inc. for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
5.56 4.06 110.33% 5 Years

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2019 2.140 -%
2018 3.590 40.2%
2017 2.560 12.3%
2016 2.280 12.9%
2015 2.020 21.7%
2014 1.660 3.8%
2013 1.600 0.0%

AbbVie Inc. (ABBV) Dividend Payment History